Editas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.60), versus $0.67 reported last year. Revenue for the quarter came in at $2.07 million, versus $3.93 million reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.